<?xml version="1.0"?>
<notificationOfRemoval>

    <schemaVersion>X0203</schemaVersion>

    <exchange>
        <cik>0001143313</cik>
        <entityName>NYSE AMERICAN LLC</entityName>
    </exchange>

    <issuer>
        <cik>1572552</cik>
        <entityName>Asterias Biotherapeutics, Inc.</entityName>
        <fileNumber>001-36646</fileNumber>
        <address>
            <street1>230 Constitution Drive</street1>
            <street2></street2>
            <city>Menlo Park</city>
            <stateOrCountryCode>CA</stateOrCountryCode>
            <stateOrCountry>CALIFORNIA</stateOrCountry>
            <zipCode>94025</zipCode>
        </address>
        <telephoneNumber>(650) 433-2900</telephoneNumber>
    </issuer>

    <descriptionClassSecurity>Warrants to purchase Series A Common Stock $0.0001 par value per share (Expiring September 29, 2017)</descriptionClassSecurity>

    <ruleProvision>17 CFR 240.12d2-2(a)(3)</ruleProvision>

    <signatureData>
        <signatureName>Benjamin Sawyer</signatureName>
        <signatureTitle>Manager</signatureTitle>
        <signatureDate>2017-09-27</signatureDate>
    </signatureData>
</notificationOfRemoval>
